NCT05026632View on ClinicalTrials.gov

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cataract
Interventions
DRUG

NPI-002 Intravitreal Implant

Implant inserted during vitrectomy.

Trial Locations (1)

Unknown

RECRUITING

Royal Adelaide Hospital, Adelaide

Sponsors
All Listed Sponsors
lead

Nacuity Pharmaceuticals, Inc.

INDUSTRY

NCT05026632 - NPI-002 Intravitreal Implant for the Delay of Cataract Progression | Biotech Hunter | Biotech Hunter